APO Research
Talk to an analyst

APO RESEARCH · REPORT

Galidesivir

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Galidesivir Market Outlook and Growth Opportunities 2026

2 January 2026190 pages

Choose your research edition.

Industry ResearchGalidesivir Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Galidesivir Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Galidesivir Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Galidesivir Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Galidesivir Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Galidesivir market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Galidesivir is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Galidesivir is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Galidesivir is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Galidesivir market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Galidesivir market include BioCryst Pharmaceuticals, Cayman Chemical, ChemScene, CliniSciences, Taiclone and Xi'an Henrikang Biotech Co., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Galidesivir market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Galidesivir and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Galidesivir sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Galidesivir market size, projected growth trends, production technologies, key applications, and end-use industries.

Galidesivir Segment by Company

BioCryst Pharmaceuticals

Cayman Chemical

ChemScene

CliniSciences

Taiclone

Xi'an Henrikang Biotech Co.

Galidesivir Segment by Type

Galidesivir Powder

Galidesivir Hydrochloride

Galidesivir Segment by Application

Yellow Fever

Marburg Virus Disease

Filovirus Infections/Ebola Virus Infection

Galidesivir Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Galidesivir status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Galidesivir market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Galidesivir significant trends, drivers, influence factors in global and regions.

6. To analyze Galidesivir competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Galidesivir market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Galidesivir and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Galidesivir.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Galidesivir market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Galidesivir industry.

Chapter 3: Detailed analysis of Galidesivir manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Galidesivir in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Galidesivir in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Galidesivir Industry Trends Table 2. Galidesivir Industry Drivers Table 3. Galidesivir Industry Opportunities and Challenges Table 4. Galidesivir Industry Restraints Table 5. Global Galidesivir Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Galidesivir Revenue Share by Company (2021-2026) Table 7. Global Galidesivir Sales Volume by Company (Tons) & (2021-2026) Table 8. Global Galidesivir Sales Volume Share by Company (2021-2026) Table 9. Global Galidesivir Average Price (US$/Kg) of Company (2021-2026) Table 10. Global Galidesivir Company Ranking, (2024-2026) & (USD Million) Table 11. Global Galidesivir Key Company Manufacturing Base & Headquarters Table 12. Global Galidesivir Company, Product Type & Application Table 13. Global Galidesivir Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Galidesivir by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Galidesivir Powder Table 18. Significant Companies of Galidesivir Hydrochloride Table 19. Global Galidesivir Sales Volume by Type 2021 VS 2025 VS 2032 (Tons) Table 20. Global Galidesivir Sales Volume by Type (2021-2026) & (Tons) Table 21. Global Galidesivir Sales Volume by Type (2027-2032) & (Tons) Table 22. Global Galidesivir Sales Volume Share by Type (2021-2026) Table 23. Global Galidesivir Sales Volume Share by Type (2027-2032) Table 24. Global Galidesivir Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Galidesivir Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Galidesivir Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Galidesivir Sales Value Share by Type (2021-2026) Table 28. Global Galidesivir Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Yellow Fever Table 30. Significant Companies of Marburg Virus Disease Table 31. Significant Companies of Filovirus Infections/Ebola Virus Infection Table 32. Global Galidesivir Sales Volume by Application 2021 VS 2025 VS 2032 (Tons) Table 33. Global Galidesivir Sales Volume by Application (2021-2026) & (Tons) Table 34. Global Galidesivir Sales Volume by Application (2027-2032) & (Tons) Table 35. Global Galidesivir Sales Volume Share by Application (2021-2026) Table 36. Global Galidesivir Sales Volume Share by Application (2027-2032) Table 37. Global Galidesivir Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Galidesivir Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Galidesivir Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Galidesivir Sales Value Share by Application (2021-2026) Table 41. Global Galidesivir Sales Value Share by Application (2027-2032) Table 42. Global Galidesivir Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 43. Global Galidesivir Sales by Region (2021-2026) & (Tons) Table 44. Global Galidesivir Sales Market Share by Region (2021-2026) Table 45. Global Galidesivir Sales by Region (2027-2032) & (Tons) Table 46. Global Galidesivir Sales Market Share by Region (2027-2032) Table 47. Global Galidesivir Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Galidesivir Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Galidesivir Sales Value Share by Region (2021-2026) Table 50. Global Galidesivir Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Galidesivir Sales Value Share by Region (2027-2032) Table 52. Global Galidesivir Market Average Price (US$/Kg) by Region (2021-2026) Table 53. Global Galidesivir Market Average Price (US$/Kg) by Region (2027-2032) Table 54. Global Galidesivir Sales by Country: 2021 VS 2025 VS 2032 (Tons) Table 55. Global Galidesivir Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Galidesivir Sales by Country (2021-2026) & (Tons) Table 57. Global Galidesivir Sales Market Share by Country (2021-2026) Table 58. Global Galidesivir Sales by Country (2027-2032) & (Tons) Table 59. Global Galidesivir Sales Market Share by Country (2027-2032) Table 60. Global Galidesivir Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Galidesivir Sales Value Market Share by Country (2021-2026) Table 62. Global Galidesivir Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Galidesivir Sales Value Market Share by Country (2027-2032) Table 64. BioCryst Pharmaceuticals Company Information Table 65. BioCryst Pharmaceuticals Business Overview Table 66. BioCryst Pharmaceuticals Galidesivir Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 67. BioCryst Pharmaceuticals Galidesivir Product Portfolio Table 68. BioCryst Pharmaceuticals Recent Development Table 69. Cayman Chemical Company Information Table 70. Cayman Chemical Business Overview Table 71. Cayman Chemical Galidesivir Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 72. Cayman Chemical Galidesivir Product Portfolio Table 73. Cayman Chemical Recent Development Table 74. ChemScene Company Information Table 75. ChemScene Business Overview Table 76. ChemScene Galidesivir Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 77. ChemScene Galidesivir Product Portfolio Table 78. ChemScene Recent Development Table 79. CliniSciences Company Information Table 80. CliniSciences Business Overview Table 81. CliniSciences Galidesivir Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 82. CliniSciences Galidesivir Product Portfolio Table 83. CliniSciences Recent Development Table 84. Taiclone Company Information Table 85. Taiclone Business Overview Table 86. Taiclone Galidesivir Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 87. Taiclone Galidesivir Product Portfolio Table 88. Taiclone Recent Development Table 89. Xi'an Henrikang Biotech Co. Company Information Table 90. Xi'an Henrikang Biotech Co. Business Overview Table 91. Xi'an Henrikang Biotech Co. Galidesivir Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 92. Xi'an Henrikang Biotech Co. Galidesivir Product Portfolio Table 93. Xi'an Henrikang Biotech Co. Recent Development Table 94. Key Raw Materials Table 95. Raw Materials Key Suppliers Table 96. Galidesivir Distributors List Table 97. Galidesivir Customers List Table 98. Research Programs/Design for This Report Table 99. Authors List of This Report Table 100. Secondary Sources Table 101. Primary Sources List of Figures Figure 1. Galidesivir Product Image Figure 2. Global Galidesivir Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Galidesivir Sales Value (2021-2032) & (US$ Million) Figure 4. Global Galidesivir Sales (2021-2032) & (Tons) Figure 5. Global Galidesivir Sales Average Price (US$/Kg) & (2021-2032) Figure 6. Global Galidesivir Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Galidesivir Powder Image Figure 10. Galidesivir Hydrochloride Image Figure 11. Global Galidesivir Sales Volume by Type (2021 VS 2025 VS 2032) & (Tons) Figure 12. Global Galidesivir Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Galidesivir Sales Volume Share by Type (2021-2032) Figure 14. Global Galidesivir Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Galidesivir Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Galidesivir Sales Value Share by Type (2021-2032) Figure 17. Yellow Fever Image Figure 18. Marburg Virus Disease Image Figure 19. Filovirus Infections/Ebola Virus Infection Image Figure 20. Global Galidesivir Sales Volume by Application (2021 VS 2025 VS 2032) & (Tons) Figure 21. Global Galidesivir Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Galidesivir Sales Volume Share by Application (2021-2032) Figure 23. Global Galidesivir Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Galidesivir Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Galidesivir Sales Value Share by Application (2021-2032) Figure 26. Global Galidesivir Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 27. Global Galidesivir Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Galidesivir Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Galidesivir Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Galidesivir Sales Value (2021-2032) & (US$ Million) Figure 31. North America Galidesivir Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Galidesivir Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Galidesivir Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Galidesivir Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Galidesivir Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Galidesivir Sales Value (2021-2032) & (US$ Million) Figure 37. South America Galidesivir Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Galidesivir Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Galidesivir Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Galidesivir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Galidesivir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Galidesivir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Galidesivir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Galidesivir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Galidesivir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Galidesivir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Galidesivir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Galidesivir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Galidesivir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Galidesivir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Galidesivir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Galidesivir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Galidesivir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Galidesivir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Galidesivir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Galidesivir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Galidesivir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Galidesivir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Galidesivir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Galidesivir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Galidesivir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Galidesivir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Galidesivir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Galidesivir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Galidesivir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Galidesivir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Galidesivir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Galidesivir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Galidesivir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Galidesivir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Galidesivir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Galidesivir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Galidesivir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Galidesivir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Galidesivir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Galidesivir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Galidesivir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Galidesivir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Galidesivir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Galidesivir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Galidesivir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Galidesivir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Galidesivir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Galidesivir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Galidesivir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Galidesivir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Galidesivir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Galidesivir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Galidesivir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Galidesivir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Galidesivir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Galidesivir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Galidesivir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Galidesivir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Galidesivir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Galidesivir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Galidesivir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Galidesivir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Galidesivir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Galidesivir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Galidesivir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Galidesivir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Galidesivir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Galidesivir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Galidesivir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Galidesivir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Galidesivir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Galidesivir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Galidesivir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Galidesivir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Galidesivir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Galidesivir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Galidesivir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Galidesivir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Galidesivir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Galidesivir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Galidesivir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Galidesivir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Galidesivir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Galidesivir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Galidesivir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Galidesivir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Galidesivir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Galidesivir Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Galidesivir Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Galidesivir Powder
  • Galidesivir Hydrochloride
Applications
  • Yellow Fever
  • Marburg Virus Disease
  • Filovirus Infections/Ebola Virus Infection
Companies covered
  • BioCryst Pharmaceuticals
  • Cayman Chemical
  • ChemScene
  • CliniSciences
  • Taiclone
  • Xi'an Henrikang Biotech Co.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Galidesivir Sales Value (2021-2032)
  4. 1.2.2 Global Galidesivir Sales Volume (2021-2032)
  5. 1.2.3 Global Galidesivir Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Galidesivir Market Dynamics
  1. 2.1 Galidesivir Industry Trends
  2. 2.2 Galidesivir Industry Drivers
  3. 2.3 Galidesivir Industry Opportunities and Challenges
  4. 2.4 Galidesivir Industry Restraints
3 Galidesivir Market by Company
  1. 3.1 Global Galidesivir Company Revenue Ranking in 2025
  2. 3.2 Global Galidesivir Revenue by Company (2021-2026)
  3. 3.3 Global Galidesivir Sales Volume by Company (2021-2026)
  4. 3.4 Global Galidesivir Average Price by Company (2021-2026)
  5. 3.5 Global Galidesivir Company Ranking (2024-2026)
  6. 3.6 Global Galidesivir Company Manufacturing Base and Headquarters
  7. 3.7 Global Galidesivir Company Product Type and Application
  8. 3.8 Global Galidesivir Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Galidesivir Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Galidesivir Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Galidesivir Market by Type
  1. 4.1 Galidesivir Type Introduction
  2. 4.1.1 Galidesivir Powder
  3. 4.1.2 Galidesivir Hydrochloride
  4. 4.2 Global Galidesivir Sales Volume by Type
  5. 4.2.1 Global Galidesivir Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Galidesivir Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Galidesivir Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Galidesivir Sales Value by Type
  9. 4.3.1 Global Galidesivir Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Galidesivir Sales Value by Type (2021-2032)
  11. 4.3.3 Global Galidesivir Sales Value Share by Type (2021-2032)
5 Galidesivir Market by Application
  1. 5.1 Galidesivir Application Introduction
  2. 5.1.1 Yellow Fever
  3. 5.1.2 Marburg Virus Disease
  4. 5.1.3 Filovirus Infections/Ebola Virus Infection
  5. 5.2 Global Galidesivir Sales Volume by Application
  6. 5.2.1 Global Galidesivir Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Galidesivir Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Galidesivir Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Galidesivir Sales Value by Application
  10. 5.3.1 Global Galidesivir Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Galidesivir Sales Value by Application (2021-2032)
  12. 5.3.3 Global Galidesivir Sales Value Share by Application (2021-2032)
6 Galidesivir Regional Sales and Value Analysis
  1. 6.1 Global Galidesivir Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Galidesivir Sales by Region (2021-2032)
  3. 6.2.1 Global Galidesivir Sales by Region: 2021-2026
  4. 6.2.2 Global Galidesivir Sales by Region (2027-2032)
  5. 6.3 Global Galidesivir Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Galidesivir Sales Value by Region (2021-2032)
  7. 6.4.1 Global Galidesivir Sales Value by Region: 2021-2026
  8. 6.4.2 Global Galidesivir Sales Value by Region (2027-2032)
  9. 6.5 Global Galidesivir Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Galidesivir Sales Value (2021-2032)
  12. 6.6.2 North America Galidesivir Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Galidesivir Sales Value (2021-2032)
  15. 6.7.2 Europe Galidesivir Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Galidesivir Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Galidesivir Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Galidesivir Sales Value (2021-2032)
  21. 6.9.2 South America Galidesivir Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Galidesivir Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Galidesivir Sales Value Share by Country, 2025 VS 2032
7 Galidesivir Country-level Sales and Value Analysis
  1. 7.1 Global Galidesivir Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Galidesivir Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Galidesivir Sales by Country (2021-2032)
  4. 7.3.1 Global Galidesivir Sales by Country (2021-2026)
  5. 7.3.2 Global Galidesivir Sales by Country (2027-2032)
  6. 7.4 Global Galidesivir Sales Value by Country (2021-2032)
  7. 7.4.1 Global Galidesivir Sales Value by Country (2021-2026)
  8. 7.4.2 Global Galidesivir Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Galidesivir Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Galidesivir Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Galidesivir Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Galidesivir Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Galidesivir Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Galidesivir Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Galidesivir Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Galidesivir Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Galidesivir Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Galidesivir Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Galidesivir Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Galidesivir Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Galidesivir Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Galidesivir Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Galidesivir Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Galidesivir Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Galidesivir Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Galidesivir Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Galidesivir Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Galidesivir Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Galidesivir Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Galidesivir Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Galidesivir Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Galidesivir Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Galidesivir Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Galidesivir Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Galidesivir Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Galidesivir Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Galidesivir Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Galidesivir Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Galidesivir Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Galidesivir Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Galidesivir Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Galidesivir Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Galidesivir Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Galidesivir Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Galidesivir Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Galidesivir Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Galidesivir Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Galidesivir Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Galidesivir Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Galidesivir Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Galidesivir Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Galidesivir Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Galidesivir Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Galidesivir Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Galidesivir Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Galidesivir Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Galidesivir Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Galidesivir Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Galidesivir Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Galidesivir Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Galidesivir Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Galidesivir Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Galidesivir Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Galidesivir Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Galidesivir Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Galidesivir Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Galidesivir Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Galidesivir Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Galidesivir Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Galidesivir Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Galidesivir Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Galidesivir Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Galidesivir Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Galidesivir Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Galidesivir Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Galidesivir Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Galidesivir Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Galidesivir Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Galidesivir Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Galidesivir Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Galidesivir Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Galidesivir Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Galidesivir Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Galidesivir Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Galidesivir Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Galidesivir Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Galidesivir Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Galidesivir Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Galidesivir Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Galidesivir Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Galidesivir Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Galidesivir Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 BioCryst Pharmaceuticals
  2. 8.1.1 BioCryst Pharmaceuticals Company Information
  3. 8.1.2 BioCryst Pharmaceuticals Business Overview
  4. 8.1.3 BioCryst Pharmaceuticals Galidesivir Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 BioCryst Pharmaceuticals Galidesivir Product Portfolio
  6. 8.1.5 BioCryst Pharmaceuticals Recent Developments
  7. 8.2 Cayman Chemical
  8. 8.2.1 Cayman Chemical Company Information
  9. 8.2.2 Cayman Chemical Business Overview
  10. 8.2.3 Cayman Chemical Galidesivir Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Cayman Chemical Galidesivir Product Portfolio
  12. 8.2.5 Cayman Chemical Recent Developments
  13. 8.3 ChemScene
  14. 8.3.1 ChemScene Company Information
  15. 8.3.2 ChemScene Business Overview
  16. 8.3.3 ChemScene Galidesivir Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 ChemScene Galidesivir Product Portfolio
  18. 8.3.5 ChemScene Recent Developments
  19. 8.4 CliniSciences
  20. 8.4.1 CliniSciences Company Information
  21. 8.4.2 CliniSciences Business Overview
  22. 8.4.3 CliniSciences Galidesivir Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 CliniSciences Galidesivir Product Portfolio
  24. 8.4.5 CliniSciences Recent Developments
  25. 8.5 Taiclone
  26. 8.5.1 Taiclone Company Information
  27. 8.5.2 Taiclone Business Overview
  28. 8.5.3 Taiclone Galidesivir Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Taiclone Galidesivir Product Portfolio
  30. 8.5.5 Taiclone Recent Developments
  31. 8.6 Xi'an Henrikang Biotech Co.
  32. 8.6.1 Xi'an Henrikang Biotech Co. Company Information
  33. 8.6.2 Xi'an Henrikang Biotech Co. Business Overview
  34. 8.6.3 Xi'an Henrikang Biotech Co. Galidesivir Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Xi'an Henrikang Biotech Co. Galidesivir Product Portfolio
  36. 8.6.5 Xi'an Henrikang Biotech Co. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Galidesivir Value Chain Analysis
  2. 9.1.1 Galidesivir Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Galidesivir Sales Mode & Process
  6. 9.2 Galidesivir Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Galidesivir Distributors
  9. 9.2.3 Galidesivir Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst